From: Use, tolerability and compliance of spironolactone in the treatment of heart failure
Compliance
50%
80%
ACE
66.4%
56.1%
ARB
68.1%
57.0%
β-blockers
71.1%
59.7%
Spironolactone
58.4%*
45.6%*